03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *
Hepaxane 6000IU : | |
Type | Medicine Authorised |
Originator | Lovenox 6000IU |
Agent | Droguerie Phenicia |
Distributor | Droguerie Phenicia |
Laboratory | Italfarmaco |
Responsible Party | Chemi SpA |
Origin | Italy |
Manufacturer | Ital Farmaco SpA |
Manufacturing Type | G |
Origin | Italy |
ATC | B01AB05 |
Hepaxane 6000IU :
Hepaxane 6000IU :
Hepaxane 6000IU :
Hepaxane 6000IU :
Hepaxane 6000IU :
Frequency | Percentage |
---|---|
Very Common | ≥ 1/10 |
Common | ≥ 1/100 - < 1/10 |
Uncommon | ≥ 1/1,000 - < 1/100 |
Rare | ≥ 1/10,000 - < 1/1,000 |
Very Rare | < 1/10,000 |
Unknown | Cannot be Estimated |
Effect | Frequency |
---|---|
Allergic reaction | Common |
Alopecia | Not known |
Anaphylactic reactions | Rare |
Anaphylactic shock | Not known |
Anaphylactoid reactions | Rare |
Cephalea | Not known |
Cholestatic liver injury | Not known |
Dermatitis bullous | Uncommon |
Ecchymosis | Very Common |
Epistaxis (Nasal bleeding) | Very Common |
Erythema | Common |
Gastrointestinal bleeding | Very Common |
Haematoma | Very Common |
Haematuria (Hematuria) | Very Common |
Haemorrhage | Very Common |
Haemorrhage intracranial | Uncommon |
Haemorrhagic anaemia | Not known |
Heparin-induced thrombocytopenia | Not known |
Hepatic enzyme increased | Very Common |
Hepatocellular injury | Not known |
Hypereosinophilia | Not known |
Hyperkalaemia | Rare |
Injection site allergic reaction | Common |
Injection site haematoma | Common |
Injection site haemorrhage | Common |
Injection site inflammation | Common |
Injection site irritation | Uncommon |
Injection site necrosis | Uncommon |
Injection site nodule | Common |
Injection site oedema | Common |
Injection site pain | Common |
Intraspinal haematoma | Not known |
Osteoporosis | Not known |
Platelet count increased | Not known |
Post procedural haematoma | Very Common |
Pruritus | Common |
Retroperitoneal haemorrhage | Rare |
Serum transaminase increased | Very Common |
Skin necrosis | Not known |
Thrombocytopenia (Thrombopenia) | Common |
Thrombocytosis | Very Common |
Urticaria | Common |
Vasculitides | Not known |
Hepaxane 6000IU :
▲ Most Expensive |
▼ Least Expensive |
P.P. = | Public Price |
P/U = | Price Per Unit |
- Products with same active ingredients |
- Products with same strength |
- Products with same route of administration |
NB : Products With Same Indication |
Different Units By MoH Code
Hepaxane 6000IU MoH 10737 :
Form | Solution for injection |
Packaging | Pre-filled Syringe |
Package Size | 10x0.6ml |
Strength | 60mg = 6000IU Anti-Xa/0.6ml |
Public Price | 4004650.65 L.L. |
Stratum | B |
NSSF | ✘ |
Quarantine | ✘ |
Reg. Number | 186619/1 |
Submission date | 02/12/2019 |
Registration Year | 13/11/2020 |
Price Comparison
● Country: | Lebanon | |
● Form: | Solution for injection | |
● Package Size: | 10x0.6ml | |
● Public Price: | 4004650.65 LBP | ( 4,004,650.65 LBP ) |
● Pack size unit used: | 60000 | |
● Cost/Unit: | 66,74 LBP | ( 66.00 LBP ) |
● Pricing Date: | 13/06/2024 |
● Country: | Germany | |
● Package Size: | 10 | |
● Public Price: | 56.12 EUR | ( 5,436,681.12 LBP ) |
● Pack size unit used: | 60000 | |
● Cost/Unit: | 0,0009 EUR | ( 0.00 LBP ) |
● Pricing Date: | 15/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Italy | |
● Package Size: | 10 | |
● Public Price: | 49.59 EUR | ( 4,804,080.84 LBP ) |
● Pack size unit used: | 60000 | |
● Cost/Unit: | 0,0008 EUR | ( 0.00 LBP ) |
● Pricing Date: | 17/12/2019 |
● Country: | Spain | |
● Package Size: | 10 jeringas precargadas de 0,6 ml | |
● Public Price: | 63.11 EUR | ( 6,113,844.36 LBP ) |
● Pack size unit used: | 60000 | |
● Cost/Unit: | 0,0011 EUR | ( 0.00 LBP ) |
● Reference: | Agencia Española de Medicamentos y Productos Sanitarios | |
● Pricing Date: | 06/05/2021 | |
● Type: | Medicine Authorised |
● Country: | Finland | |
● Package Size: | 10x0.6ml | |
● Public Price: | 46.04 EUR | ( 4,460,171.04 LBP ) |
● Pack size unit used: | 60000 | |
● Cost/Unit: | 0,0008 EUR | ( 0.00 LBP ) |
● Reference: | Kela | |
● Pricing Date: | 22/04/2021 | |
● Type: | Medicine Authorised |
You have to register to view this info
Drop File